Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-065954
Filing Date
2017-12-29
Accepted
2017-12-29 18:11:09
Documents
2
Period of Report
2017-12-19

Document Format Files

Seq Description Document Type Size
1 FORM 3 tv482306_3.html 3  
1 FORM 3 tv482306_3.xml 3 2408
2 EXHIBIT 24 tv482306_ex24.htm EX-24 8511
  Complete submission text file 0001144204-17-065954.txt   12572
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address UNIT 2706 MICHELANGELO TOWERS 8 MAUDE STREET SANDTON T3 2416
Business Address
Shabtai Gilad (Reporting) CIK: 0001726027 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31326 | Film No.: 171282833